Skip to main content

Fine Foods & Pharmaceuticals N.T.M. S.p.A. (FF.MI)

53.4Fair

ValueMarkers Composite Index

Top 48%#23,304 of 44,707
Undervalued

82% below intrinsic value ($56)

UndervaluedFair ValueOvervalued
Piotroski
6/9
Neutral
Beneish
-0.69
High Risk
Altman
2.30
Grey Zone
DCF Value
$56
Undervalued
ROIC
5.4%
Low
P/E
13.9
Value
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Fine Foods & Pharmaceuticals N.T.M. S.p.A. (FF.MI) — VMCI valuation read

Fine Foods & Pharmaceuticals N.T.M. S.p.A. (FF.MI) carries a VMCI composite of 53/100, 3 points above the Consumer Defensive sector median of 50. Among mid-cap names, that gap places FF.MI in the top third on the five-pillar weighting (Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%).

The FF.MI insider tape has been silent for the past 30 days on Form 4. Where executives neither buy nor sell, the bull and bear cases lean harder on filings cadence and the next earnings line.

**Investor frame.** Value reads FF.MI trades at 20.0x earnings, 11% above the Consumer Defensive median of 18.0x, which compresses or extends through the 11.0x EV/EBITDA versus a Consumer Defensive 12.0x. Quality: ROIC of 10.0% sits 0.0pp above the Consumer Defensive median (10.0%). Risk: net debt to EBITDA of -0.9x leaves covenant headroom, the line to track on Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s next 10-Q.

FF.MI fell 2.8% over the trailing 7 days, with a +4.0% read on a 30-day basis.

Fine Foods & Pharmaceuticals N.T.M. S.p.A. engages in the contract development and manufacturing of oral solid forms for the pharmaceutical and nutraceutical industries. It offers pharmaceutical products, including powders and granules, capsules, tablets, film-coated tablets, effervescent granules, and hard gelatine capsules. The company also provides nutraceutical products comprising soluble and effervescent powders and granules, soluble, effervescent and chewable tablets, fast melting/sublingual tablets, film-coated tablets, and hard gelatin capsules for various therapeutic areas, such as probiotics, multivitamins and minerals, immune systems, sleep and relax, gastrointestinal system, circulatory system, osteoarticular system, urinary system, women health, beauty, healthy ageing, and mental wellbeing. In addition, the company manufactures and trades in cosmetics products consisting of hair care, skin care, liquid detergents for personal hygiene, skin care emulsions, oral hygiene, deodorants, alcohol-based perfumery, bath and shower gel, shampoo and conditioners, shaping waxes, mouthwash and breath products, creams, gel and toothpaste, roll-on, stick and vapo spray deodrants, intimate cleansers, emulsions and microemulsions, gels, and liquid soaps; medical surgical aids and medical devices; antiseptics for undamaged skin, hand gel, pre-injection, hydroalcoholic surfaces, and iodine; and orthodontic cleaning tablets, disinfectants, and decongestant nasal sprays. The company was founded in 1984 and is headquartered in Verdellino, Italy.

CEO: Marco Francesco Eigenmann779 employeesITwww.finefoods.it

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in FF.MI’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.